Related Experiment Videos
Diagnostic delay in neurofibromatosis type 1
M H Cnossen1, F J Smit, A de Goede-Bolder
1University Hospital Sophia/Dijkzigt, Erasmus University Rotterdam, The Netherlands.
European Journal of Pediatrics
|June 1, 1997
Summary
Early diagnosis of neurofibromatosis type 1 (NF1) is significantly delayed, impacting patient care. Increased awareness of NF1 symptoms can facilitate earlier diagnosis and improve outcomes for affected individuals and families.
Area of Science:
- Medical Genetics
- Pediatric Neurology
- Clinical Diagnosis
Background:
- Neurofibromatosis type 1 (NF1) is a genetic disorder requiring multidisciplinary care.
- Diagnostic delays for NF1 have been observed, potentially impacting patient management.
- A dedicated NF1 center has provided services since 1985.
Purpose of the Study:
- To evaluate the timeliness of NF1 diagnosis in a cohort of patients.
- To assess the impact of diagnostic delays on patient treatment.
- To understand parental perspectives on NF1 diagnosis and reproductive choices.
Main Methods:
- Interview-based study involving parents of 68 children and 24 affected adults with NF1.
- Analysis of treatment history in relation to diagnosis.
- Assessment of parental attitudes towards early and prenatal diagnosis.
Main Results:
- Significant delays in NF1 diagnosis were noted, with 50% of children and 33% of adults treated for symptoms before diagnosis.
- Despite full penetrance by age 5, 35% of children remained undiagnosed.
- Parents expressed a preference for early NF1 diagnosis and a positive attitude towards prenatal diagnosis, though few would terminate an affected pregnancy.
Conclusions:
- There is a substantial overall delay in the diagnosis of NF1.
- Enhanced knowledge of NF1 symptoms among healthcare providers and the public is crucial for enabling earlier diagnosis.
- Early diagnosis of NF1 offers significant benefits for patients and their families.